Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Nov;49(5):682–685. doi: 10.1136/gut.49.5.682

Improving prognosis following a first variceal haemorrhage over four decades

P McCormick 1, C O'Keefe 1
PMCID: PMC1728509  PMID: 11600472

Abstract

BACKGROUND—Variceal bleeding is a frequent cause of death in patients with cirrhosis and portal hypertension. Over the past 40 years a number of new techniques have been introduced to control active variceal haemorrhage. Many randomised controlled trials were performed to evaluate these new therapies. While most have demonstrated efficacy in controlling haemorrhage few showed improved survival.
AIM—The aim of this study was to investigate whether the prognosis for cirrhotic patients following a first variceal haemorrhage has improved over the past four decades.
PATIENTS AND METHODS—A total of 1475 patients included in the control or untreated arms of randomised controlled prophylactic trials for the primary prevention of variceal haemorrhage between 1960 and 2000. Twenty eight eligible randomised controlled studies were included. Over the 40 year period of observation there was a reduction in bleeding related mortality over time from approximately 65% to approximately 40% (p=0.024).
CONCLUSION—This study suggests that there has been a significant reduction in bleeding related mortality in patients with cirrhosis and portal hypertension over the past 40 years.


Keywords: portal hypertension; cirrhosis; variceal bleeding; primary prophylaxis; prognosis

Full Text

The Full Text of this article is available as a PDF (158.6 KB).

Figure 1  .

Figure 1  

Open in a new tab

Percentage mortality for patients who bled in the control arms of prophylactic trials over the 40 years, 1960-2000. Bleeding related mortality declined significantly over time, p=0.026. The slope of the regression line is −0.85 ± 0.36 with r=−0.42.

graphic file with name gut-tflm.f1.jpg

Open in a new tab

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andreani T., Poupon R. E., Balkau B. J., Trinchet J. C., Grange J. D., Peigney N., Beaugrand M., Poupon R. Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo. Hepatology. 1990 Dec;12(6):1413–1419. doi: 10.1002/hep.1840120624. [DOI] [PubMed] [Google Scholar]
  2. BAKER L. A., SMITH C., LIEBERMAN G. The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding. Am J Med. 1959 Feb;26(2):228–237. doi: 10.1016/0002-9343(59)90311-0. [DOI] [PubMed] [Google Scholar]
  3. Burroughs A. K., Mezzanotte G., Phillips A., McCormick P. A., McIntyre N. Cirrhotics with variceal hemorrhage: the importance of the time interval between admission and the start of analysis for survival and rebleeding rates. Hepatology. 1989 Jun;9(6):801–807. doi: 10.1002/hep.1840090602. [DOI] [PubMed] [Google Scholar]
  4. Burroughs A. K. The natural history of varices. J Hepatol. 1993;17 (Suppl 2):S10–S13. doi: 10.1016/s0168-8278(05)80448-9. [DOI] [PubMed] [Google Scholar]
  5. CONN H. O., LINDENMUTH W. W. PROPHYLACTIC PORTACAVAL ANASTOMOSIS IN CIRRHOTIC PATIENTS WITH ESOPHAGEAL VARICES: A PROGRESS REPORT OF A CONTINUING STUDY. N Engl J Med. 1965 Jun 17;272:1255–1263. doi: 10.1056/NEJM196506172722402. [DOI] [PubMed] [Google Scholar]
  6. Chen C. H., Sheu J. C., Huang G. T., Lee H. S., Yang P. M., Wong J. M., Chen D. S. Characteristics of hepatocellular carcinoma presenting with variceal bleeding. J Gastroenterol Hepatol. 1998 Feb;13(2):170–174. doi: 10.1111/j.1440-1746.1998.tb00633.x. [DOI] [PubMed] [Google Scholar]
  7. Conn H. O., Grace N. D., Bosch J., Groszmann R. J., Rodés J., Wright S. C., Matloff D. S., Garcia-Tsao G., Fisher R. L., Navasa M. Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group. Hepatology. 1991 May;13(5):902–912. [PubMed] [Google Scholar]
  8. Conn H. O., Lindenmuth W. W., May C. J., Ramsby G. R. Prophylactic portacaval anastomosis. Medicine (Baltimore) 1972 Jan;51(1):27–40. doi: 10.1097/00005792-197201000-00002. [DOI] [PubMed] [Google Scholar]
  9. D'Amico G., Luca A. Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin Gastroenterol. 1997 Jun;11(2):243–256. doi: 10.1016/s0950-3528(97)90038-5. [DOI] [PubMed] [Google Scholar]
  10. D'Amico G., Pagliaro L., Bosch J. The treatment of portal hypertension: a meta-analytic review. Hepatology. 1995 Jul;22(1):332–354. doi: 10.1002/hep.1840220145. [DOI] [PubMed] [Google Scholar]
  11. Dagradi A. E. The natural history of esophageal varices in patients with alcoholic liver cirrhosis. An endoscopic and clinical study. Am J Gastroenterol. 1972 Jun;57(6):520–540. [PubMed] [Google Scholar]
  12. De Franchis R., Primignani M., Arcidiacono P. G., Rizzi P. M., Vitagliano P., Vazzoler M. C., Arcidiacono R., Rossi A., Zambelli A., Cosentino F. Prophylactic sclerotherapy in high-risk cirrhotics selected by endoscopic criteria. A multicenter randomized controlled trial. Gastroenterology. 1991 Oct;101(4):1087–1093. doi: 10.1016/0016-5085(91)90738-7. [DOI] [PubMed] [Google Scholar]
  13. El-Serag H. B., Everhart J. E. Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs. Am J Gastroenterol. 2000 Dec;95(12):3566–3573. doi: 10.1111/j.1572-0241.2000.03376.x. [DOI] [PubMed] [Google Scholar]
  14. Goulis J., Armonis A., Patch D., Sabin C., Greenslade L., Burroughs A. K. Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology. 1998 May;27(5):1207–1212. doi: 10.1002/hep.510270504. [DOI] [PubMed] [Google Scholar]
  15. Hayes P. C., Davis J. M., Lewis J. A., Bouchier I. A. Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet. 1990 Jul 21;336(8708):153–156. doi: 10.1016/0140-6736(90)91668-z. [DOI] [PubMed] [Google Scholar]
  16. Idéo G., Bellati G., Fesce E., Grimoldi D. Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study. Hepatology. 1988 Jan-Feb;8(1):6–9. doi: 10.1002/hep.1840080103. [DOI] [PubMed] [Google Scholar]
  17. Jackson F. C., Perrin E. B., Smith A. G., Dagradi A. E., Nadal H. M. A clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation. Am J Surg. 1968 Jan;115(1):22–42. doi: 10.1016/0002-9610(68)90127-x. [DOI] [PubMed] [Google Scholar]
  18. Kjaergard L. L., Nikolova D., Gluud C. Randomized clinical trials in HEPATOLOGY: predictors of quality. Hepatology. 1999 Nov;30(5):1134–1138. doi: 10.1002/hep.510300510. [DOI] [PubMed] [Google Scholar]
  19. Kobe E., Zipprich B., Schentke K. U., Nilius R. Prophylactic endoscopic sclerotherapy of esophageal varices--a prospective randomized trial. Endoscopy. 1990 Nov;22(6):245–248. doi: 10.1055/s-2007-1012862. [DOI] [PubMed] [Google Scholar]
  20. Koch H., Henning H., Grimm H., Soehendra N. Prophylactic sclerosing of esophageal varices--results of a prospective controlled study. Endoscopy. 1986 Mar;18(2):40–43. doi: 10.1055/s-2007-1018322. [DOI] [PubMed] [Google Scholar]
  21. Lay C. S., Tsai Y. T., Teg C. Y., Shyu W. S., Guo W. S., Wu K. L., Lo K. J. Endoscopic variceal ligation in prophylaxis of first variceal bleeding in cirrhotic patients with high-risk esophageal varices. Hepatology. 1997 Jun;25(6):1346–1350. doi: 10.1002/hep.510250608. [DOI] [PubMed] [Google Scholar]
  22. Lebrec D., De Fleury P., Rueff B., Nahum H., Benhamou J. P. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980 Dec;79(6):1139–1144. [PubMed] [Google Scholar]
  23. Lebrec D., Poynard T., Capron J. P., Hillon P., Geoffroy P., Roulot D., Chaput J. C., Rueff B., Benhamou J. P. Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial. J Hepatol. 1988 Aug;7(1):118–125. doi: 10.1016/s0168-8278(88)80515-4. [DOI] [PubMed] [Google Scholar]
  24. Levacher S., Letoumelin P., Pateron D., Blaise M., Lapandry C., Pourriat J. L. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet. 1995 Sep 30;346(8979):865–868. doi: 10.1016/s0140-6736(95)92708-5. [DOI] [PubMed] [Google Scholar]
  25. Lo G. H., Lai K. H., Cheng J. S., Lin C. K., Hsu P. I., Chiang H. T. Prophylactic banding ligation of high-risk esophageal varices in patients with cirrhosis: a prospective, randomized trial. J Hepatol. 1999 Sep;31(3):451–456. doi: 10.1016/s0168-8278(99)80036-1. [DOI] [PubMed] [Google Scholar]
  26. Paquet K. J. Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial. Endoscopy. 1982 Jan;14(1):4–5. doi: 10.1055/s-2007-1021560. [DOI] [PubMed] [Google Scholar]
  27. Pascal J. P., Cales P. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med. 1987 Oct 1;317(14):856–861. doi: 10.1056/NEJM198710013171403. [DOI] [PubMed] [Google Scholar]
  28. Piai G., Cipolletta L., Claar M., Marone G., Bianco M. A., Forte G., Iodice G., Mattera D., Minieri M., Rocco P. Prophylactic sclerotherapy of high-risk esophageal varices: results of a multicentric prospective controlled trial. Hepatology. 1988 Nov-Dec;8(6):1495–1500. doi: 10.1002/hep.1840080605. [DOI] [PubMed] [Google Scholar]
  29. Poynard T., Calès P., Pasta L., Ideo G., Pascal J. P., Pagliaro L., Lebrec D. Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med. 1991 May 30;324(22):1532–1538. doi: 10.1056/NEJM199105303242202. [DOI] [PubMed] [Google Scholar]
  30. Pugh R. N., Murray-Lyon I. M., Dawson J. L., Pietroni M. C., Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973 Aug;60(8):646–649. doi: 10.1002/bjs.1800600817. [DOI] [PubMed] [Google Scholar]
  31. Pötzi R., Bauer P., Reichel W., Kerstan E., Renner F., Gangl A. Prophylactic endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. A multicentre prospective controlled randomised trial in Vienna. Gut. 1989 Jun;30(6):873–879. doi: 10.1136/gut.30.6.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Resnick R. H., Chalmers T. C., Ishihara A. M., Garceau A. J., Callow A. D., Schimmel E. M., O'Hara E. T. A controlled study of the prophylactic portacaval shunt. A final report. Ann Intern Med. 1969 Apr;70(4):675–688. doi: 10.7326/0003-4819-70-4-675. [DOI] [PubMed] [Google Scholar]
  33. Russo A., Giannone G., Magnano A., Passanisi G., Longo C. Prophylactic sclerotherapy in nonalcoholic liver cirrhosis: preliminary results of a prospective controlled randomized trial. World J Surg. 1989 Mar-Apr;13(2):149–153. doi: 10.1007/BF01658391. [DOI] [PubMed] [Google Scholar]
  34. Santangelo W. C., Dueno M. I., Estes B. L., Krejs G. J. Prophylactic sclerotherapy of large esophageal varices. N Engl J Med. 1988 Mar 31;318(13):814–818. doi: 10.1056/NEJM198803313181304. [DOI] [PubMed] [Google Scholar]
  35. Sarin S. K., Guptan R. K., Jain A. K., Sundaram K. R. A randomized controlled trial of endoscopic variceal band ligation for primary prophylaxis of variceal bleeding. Eur J Gastroenterol Hepatol. 1996 Apr;8(4):337–342. doi: 10.1097/00042737-199604000-00010. [DOI] [PubMed] [Google Scholar]
  36. Sauerbruch T., Wotzka R., Köpcke W., Härlin M., Heldwein W., Bayerdörffer E., Sander R., Ansari H., Starz I., Paumgartner G. Prophylactic sclerotherapy before the first episode of variceal hemorrhage in patients with cirrhosis. N Engl J Med. 1988 Jul 7;319(1):8–15. doi: 10.1056/NEJM198807073190102. [DOI] [PubMed] [Google Scholar]
  37. Triger D. R., Smart H. L., Hosking S. W., Johnson A. G. Prophylactic sclerotherapy for esophageal varices: long-term results of a single-center trial. Hepatology. 1991 Jan;13(1):117–123. [PubMed] [Google Scholar]
  38. Witzel L., Wolbergs E., Merki H. Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study. Lancet. 1985 Apr 6;1(8432):773–775. doi: 10.1016/s0140-6736(85)91444-8. [DOI] [PubMed] [Google Scholar]
  39. Wördehoff D., Spech H. J. Prophylaktische Osophagusvarizensklerosierung. Ergebnisse einer prospektiven, randomisierten Langzeitstudie über 7 Jahre. Dtsch Med Wochenschr. 1987 Jun 12;112(24):947–951. doi: 10.1055/s-2008-1068172. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES